← Leaderboards
Sowmya Yelamanchili
University Of Nebraska Medical Center
$4,184,204
Attributed
$7,232,741
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,232,741 · 5
By mechanism
R01$6,382,541 · 3
R21$850,200 · 2
Top collaborators
- Gurudutt Pendyala7 shared
- Rick A Bevins6 shared
- Peng Jiang4 shared
- Fatah Kashanchi3 shared
- Howard S. Fox2 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Gurudutt Pendyala$3,819,534
- Anuja Ghorpade$11,383,660
- Nora E Sarvetnick$25,892,311
- Honghong Yao$729,136
- Subhash Chand$307,000
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBrainPathway InteractionsExtracellular VesiclesCellsBiogenesisMethamphetamineChronicPsychostimulantNeuronsMicrornasNeurogliaMediatingAffectExosomeBiochemicalDendritic SpinesPharmaceutical PreparationsMethamphetamine EffectNeurotoxicityFoundationsDesignMicrogliaVesicular Release
Grant awards (21)
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$520,609
R01 · FY2025 · DA · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$495,815
R01 · FY2024 · DA · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$531,074
R01 · FY2023 · DA · contact PI
Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity$549,391
R01 · FY2022 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$473,268
R01 · FY2022 · DA
Extracellular vesicles, meth relapse and sex differences$47,029
R01 · FY2022 · DA
Extracellular vesicles, meth relapse and sex differences$30,485
R01 · FY2022 · DA
Extracellular vesicles, meth relapse and sex differences$569,253
R01 · FY2021 · DA
Extracellular vesicles, meth relapse and sex differences$431,147
R01 · FY2020 · DA
Role of extracellular vesicles in methamphetamine mediated neurotoxicity$318,730
R01 · FY2020 · DA · contact PI
Role of extracellular vesicles in methamphetamine mediated neurotoxicity$448,264
R01 · FY2019 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$411,529
R01 · FY2019 · DA
Role of extracellular vesicles in methamphetamine and HIV induced neurotoxicity$190,323
R21 · FY2019 · DA · contact PI
Role of extracellular vesicles in methamphetamine and HIV induced neurotoxicity$4,340
R21 · FY2019 · DA · contact PI
Role of extracellular vesicles in methamphetamine mediated neurotoxicity$461,067
R01 · FY2018 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$407,399
R01 · FY2018 · DA
Role of extracellular vesicles in methamphetamine and HIV induced neurotoxicity$241,662
R21 · FY2018 · DA · contact PI
Role of extracellular vesicles in methamphetamine mediated neurotoxicity$328,317
R01 · FY2017 · DA · contact PI
Role of extracellular vesicles in methamphetamine mediated neurotoxicity$359,164
R01 · FY2016 · DA · contact PI
Elucidating the role of exosomal miR-21 in SIV/HIV neurological dysfunction$188,125
R21 · FY2016 · MH
Elucidating the role of exosomal miR-21 in SIV/HIV neurological dysfunction$225,750
R21 · FY2015 · MH